Pauls Dietrich John's Form 4 filing
DiaMedica Therapeutics Inc. (DMAC) · filed Aug 12, 2026
- Accession no.
- 0001760123-26-000004
- Filed
- Aug 12, 2026, 4:23 PM ET
- Trade date
- Aug 10, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pauls Dietrich JohnCIK 0001760123 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Voting Common Shares, no par value per share | AGrant or awardAcquired | +60,200 | $0.00 | $0 | 128,791 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.